Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ

Supplementary Data

Supplementary Data

Files in this Data Supplement:

• Supplementary Data - Doc file
• Supplementary Figure 1 - tif file
• Supplementary Figure 2 - tif file
• Supplementary Figure 3 - tif file
• Supplementary Figure 4 - tif file
• Supplementary Figure 5 - tif file
• Supplementary Figure 6 - tif file
• Supplementary Figure_legend - doc file